AK Medical Holdings Limited

Research AK Medical Holdings Limited (1789.HK) on Bullrun: market cap HKD 4.77B, P/E 11.9, dividend yield 2.6%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is HKD 4.77B; P/E is 11.9; dividend yield is 2.6%.

Peer valuation comparison

Latest P/E is 11.88x versus a Healthcare sector median of 21.74x (45.4% below).

Latest dividend yield is 2.61% versus a Healthcare sector median of 2.4% (8.8% above).

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025CNY 1.48BCNY 339.09MCNY 272.00M60.5%0.3CNY 357.23MCNY 86.43MCNY 2.91B
FY2024CNY 1.35BCNY 273.93MCNY 289.11M60.0%0.24CNY 352.17MCNY 99.39MCNY 2.64B
FY2023CNY 1.09BCNY 182.10M-CNY 162.14M61.7%0.16CNY 331.22MCNY 84.20MCNY 2.39B
FY2022CNY 1.05BCNY 204.77MCNY 121.20M60.5%0.18CNY 625.83MCNY 38.78MCNY 2.24B

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-17HKD 4.77B11.92.6%0.12

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0.12 HKD, yield 2.6%.

YearDividends/share
FY20250.07 CNY
FY20240.05 CNY
FY20230.06 CNY
FY20220.03 CNY
FY20210.04 CNY

About AK Medical Holdings Limited

AK Medical Holdings Limited, an investment holding company, designs, develops, produces, and markets orthopedic joint implants and related products in the People's Republic of China, the United Kingdom, and internationally. It offers knee, hip, and spinal and trauma replacement implants;

Related stock research

Other Healthcare stocks

Frequently asked questions

What is AK Medical Holdings Limited's market cap?

AK Medical Holdings Limited's market capitalization is HKD 4.77B.

What is AK Medical Holdings Limited's P/E ratio?

AK Medical Holdings Limited's price-to-earnings (P/E) ratio is 11.9.

Does AK Medical Holdings Limited pay a dividend?

AK Medical Holdings Limited has a dividend yield of 2.6%.

What does AK Medical Holdings Limited do?

AK Medical Holdings Limited, an investment holding company, designs, develops, produces, and markets orthopedic joint implants and related products in the People's Republic of China, the United Kingdom, and internationally. It offers knee, hip, and spinal and trauma replacement implants; and 3D-printed products, such as 3D-printed hip and knee replacement implants, 3D-printed spinal and trauma implants, as well as customized joint, pelvic, spinal and trauma implant products and customized value-added surgical services and orthopedic surgical robots.